The Humanized Chimeric anti-AMHR2 (Murlentamab Biosimilar) antibody has been validated for . It is suitable to detect AMHR2 (Murlentamab Biosimilar) in samples from Human.
Catalog No. ABIN7597837
Quick Overview for Recombinant AMHR2 (Murlentamab Biosimilar) antibody (ABIN7597837)
Target
AMHR2 (Murlentamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This AMHR2 (Murlentamab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
Expression System
Mammalian cells
Purpose
Research Grade Murlentamab Biosimilar Antibody
Specificity
MIS type II receptor, MISR2, AMHR2, AMHR, Anti-Muellerian hormone type II receptor, MRII, AMH type II receptor, MISRII, Anti-Muellerian hormone type-2 receptor
Purification
Protein A or G purified from cell culture supernatant.
Reactivity: Human
ELISA, FACS, BLI, Func, SPR
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
0.01M PBS, pH 7.4.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Expiry Date
12 months
Target
AMHR2 (Murlentamab Biosimilar)
Alternative Name
Murlentamab Biosimilar
Target Type
Biosimilar
Background
MIS type II receptor, MISR2, AMHR2, AMHR, Anti-Muellerian hormone type II receptor, MRII, AMH type II receptor, MISRII, Anti-Muellerian hormone type-2 receptor